BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36586494)

  • 1. Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma.
    Wu XH; Zhu JM; Lin BH; Qiu QR; Ruan ZT; Wei Y; Xue XY; Zheng QS; Chen SH; Xu N
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):666-675. PubMed ID: 36586494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
    He H; Jin Z; Dai J; Wang H; Sun J; Xu D
    Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features.
    Cen D; Xu L; Zhang S; Chen Z; Huang Y; Li Z; Liang B
    Eur Radiol; 2019 Oct; 29(10):5415-5422. PubMed ID: 30877466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.
    Kocak B; Durmaz ES; Kaya OK; Kilickesmez O
    Acta Radiol; 2020 Jun; 61(6):856-864. PubMed ID: 31635476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram combining pre-operative clinical characteristics and spectral CT parameters for predicting the WHO/ISUP pathological grading in clear cell renal cell carcinoma.
    Zhang H; Li F; Jing M; Xi H; Zheng Y; Liu J
    Abdom Radiol (NY); 2024 Apr; 49(4):1185-1193. PubMed ID: 38340180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material.
    Zhang Y; Sun Z; Ma H; Wang C; Zhang W; Liu J; Li M; Zhang Y; Guo H; Ba X
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15855-15865. PubMed ID: 37672076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group.
    Shinagare AB; Vikram R; Jaffe C; Akin O; Kirby J; Huang E; Freymann J; Sainani NI; Sadow CA; Bathala TK; Rubin DL; Oto A; Heller MT; Surabhi VR; Katabathina V; Silverman SG
    Abdom Imaging; 2015 Aug; 40(6):1684-92. PubMed ID: 25753955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study.
    Nie P; Yang G; Wang Y; Xu Y; Yan L; Zhang M; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Wang N; Duan S; Wang X; Wang Z
    Eur Radiol; 2023 Dec; 33(12):8858-8868. PubMed ID: 37389608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
    Yang Y; Huang H; Liang H
    J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma.
    Tang F; Tang Z; Lu Z; Cai Y; Lai Y; Mai Y; Li Z; Lu Z; Zhang J; Li Z; He Z
    BMC Urol; 2022 Dec; 22(1):203. PubMed ID: 36496360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
    Karlo CA; Di Paolo PL; Chaim J; Hakimi AA; Ostrovnaya I; Russo P; Hricak H; Motzer R; Hsieh JJ; Akin O
    Radiology; 2014 Feb; 270(2):464-71. PubMed ID: 24029645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.
    Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B
    Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings.
    Feng Z; Zhang L; Qi Z; Shen Q; Hu Z; Chen F
    Front Oncol; 2020; 10():279. PubMed ID: 32185138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting postoperative recurrence of stage Ⅰ-Ⅲ renal clear cell carcinoma based on preoperative CT radiomics feature nomogram].
    Zhang H; Yin F; Chen M; Qi A; Yang L; Cui W; Yang S; Wen G
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(9):1358-1365. PubMed ID: 34658350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
    Zhou Q; Qi Y; Wang Z; Zeng H; Zhang H; Liu Z; Huang Q; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Xu L; Dai B; Guo J; Zhu Y; Zhang W; Xu J
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32371459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.